The Mark E. Josephson Twenty-Ninth Annual State-of-the -Art Arrhythmia Symposium 2022

---

LIVEAAPACMECNEConferences & Symposia

Saturday, September 10, 2022, 7:30 AM - 5:00 PM, Hyatt at Penn's Landing, Philadelphia, PA

In-Person Registration is now closed.

Walk-ins are welcome on site.

This is the 29th year for the State-of-the-Art Arrhythmia Symposium. Using a combination of case presentations with audience participation, didactic presentations, and question and answer sessions, our goal is to educate the participants in state of the art information on invasive and non-invasive electrophysiologic and electrocardiographic tools used in the current diagnosis, evaluation and treatment of cardiac rhythm disorders. The program is taught by members of the faculty and staff from the University of Pennsylvania Health System, Department of Electrophysiology, in addition to invited speakers from other institutions. The course is structured to meet the educational needs of electrophysiologists, cardiologists, internists, nurses, and associated professionals with an interest in the care of patients with cardiac rhythm disorders. In addition to the morning session with lectures aimed at the entire audience, there are three breakout sessions in the afternoon aimed at 1) associated professionals 2) general cardiology and 3) an advanced electrophysiology session aimed at EP fellows, electrophysiologists, and EP lab staff.

The State-of-the-Art Arrhythmia Symposium is coupled each year with the Leonard N. Horowitz Memorial Lecture which is given by a leader in cardiology.

1. Discuss the use and value of new techniques and technologies employed for complex EP device and ablation cases.
2. Assess the differences in the various oral anticoagulants including appropriate use, dosing, risks, and contraindications
3. Identify ECG clues to detect patients at risk for sudden death.
4. Describe the indications for cardiac resynchronization therapy and conduction system pacing, based on QRS morphology and duration, symptoms, functional class, ejection fraction, and type of heart disease
5. Indicate when to recommend antiarrhythmic medications for patients with atrial fibrillation and flutter and how to select the most appropriate drug considering the patient’s age and comorbidities
6. Describe the complexities regarding arrhythmia management in patients with congenital heart disease
7. Describe the appropriate evaluation and treatment for patients presenting with syncope.
8. Explain the indications and methods to diagnose inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies, including the roles and limitations of genetic testing and the importance and limitations of family screening
9. Apply into practice the newest information regarding evaluation and treatment of atrial arrhythmias including screening for episodes and ablation indications/techniques/endpoints
10. Describe the indications, contraindications, and complications associated with left atrial (LA) appendage occlusion and closure
11. Use the methods, techniques, associated tools, and equipment including emerging technologies to perform to catheter ablation of atrial fibrillation and flutter
12. Manage perioperative anticoagulation, including bridging when appropriate
13. Explain the indications and methods to diagnose inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies, including the roles and limitations of genetic testing and the importance and limitations of family screening.

AMA PRA Category 1 Credits™ (7.75 hours), American Academy of Physician Assistants (7.75 hours), NCPD Hours (ANCC) (7.75 hours), Non-Physician Attendance / Participation (7.75 hours)


The University reserves the right to cancel or postpone any course due to unforeseen circumstances. In the event of cancellation or postponement, the University will refund registration fees but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines, and travel agencies.

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, September 10, 2022

The CME/CNE-accredited symposium, The Mark E. Josephson Twenty-Ninth Annual State-of-the-Art Arrhythmia Symposium 2022 will be presented Saturday, September 10, 2022, at the Hilton Philadelphia at Penn’s Landing, 201 South Christopher Columbus Boulevard, Philadelphia, PA 19106.  

Exhibit space will be made available during this event at $4,000 per table. Each exhibitor will receive a standard 8’ table.  A tablecloth and electric will be provided, if required. Your company will be acknowledged in the conference materials, on the signage and by the course director(s) during the welcome address. Exhibitors will be set-up in the lobby, just outside of the auditorium.  The CME activities will be held behind closed doors, in the auditorium, separate and apart from the exhibits.  We anticipate approximately 200 attendees and speakers.  Please act quickly as space is limited!

If you are interested in reserving exhibit space, please complete and sign the Exhibitor Agreement and return it along with your exhibit fee to my attention.  Please see the exhibitor agreement for remittance details.  Please feel free to contact me with any questions.